Tyche Industries Limited (BOM:532384)
India · Delayed Price · Currency is INR 136.80
+3.35 (2.51%)
At close: May 29, 2026
Tyche Industries Revenue
In the fiscal year ending March 31, 2026, Tyche Industries had annual revenue of 628.56M INR, down -5.08%. Tyche Industries had revenue of 191.51M in the quarter ending March 31, 2026, with 46.02% growth.
Revenue
628.56M
Revenue Growth
-5.08%
P/S Ratio
2.23
Revenue / Employee
3.88M
Employees
162
Market Cap
1.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 628.56M | -33.65M | -5.08% |
| Mar 31, 2025 | 662.22M | -34.63M | -4.97% |
| Mar 31, 2024 | 696.84M | -59.16M | -7.83% |
| Mar 31, 2023 | 756.00M | 125.84M | 19.97% |
| Mar 31, 2022 | 630.16M | -163.86M | -20.64% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 3.91B |
| Kimia Biosciences | 1.26B |
| Panchsheel Organics | 1.03B |
| Smruthi Organics | 1.02B |
| Resonance Specialties | 918.89M |
| Vasundhara Rasayans | 386.27M |
| Accretion Nutraveda | 337.16M |
| Auro Laboratories | 284.46M |